S SHACKELFORD PHARMA
LIVE

Serial Number

97063826

Owner

Shackelford Pharma Inc.

Attorney

Steve Zemanick

Filing Date

Oct 7, 2021

Add to watchlist:

No watchlists yet
View on USPTO

S SHACKELFORD PHARMA Trademark

Serial Number: 97063826

S SHACKELFORD PHARMA is a trademark filed by Shackelford Pharma Inc. on October 7, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Shackelford Pharma Inc.

1000-355 Burrard Street
British Columbia V6C2G8 , CA

Entity Type: 03

Trademark Details

Filing Date

October 7, 2021

Registration Date

Not Registered

Goods & Services

(Based on Intent To Use) Pharmaceutical preparations for treating neurological diseases and disorders; pharmaceutical preparations for treating headaches, neurodegeneration, neurogenesis, epilepsy, childhood epilepsy, paediatric encephalopathies, pain, cancer, managing the effects of chemotherapy, Tourette Syndrome, post-traumatic stress disorder (PTSD), nausea, vomiting, premenstrual syndrome (PMS), neurologic conditions, sleep disorders, cognitive decline, facial pain, spasms, gastrointestinal diseases, rare diseases, Alzheimer's disease, appetite loss, cancer, Crohn's disease, anorexia, bulimia, epilepsy, glaucoma, schizophrenia, multiple sclerosis, muscle spasms, nausea, pain, headaches, wasting syndrome (cachexia), and diseases classified as "orphan" by the US Food and Drug Administration

(Based on 44(d) Priority Application) (Based on Intent to Use) Providing consumer, business and industry information to the public in the fields of medical cannabis, the treatment of medical conditions, and research in the field of medical marijuana

(Based on 44(d) Priority Application) (Based on Intent to Use) Providing information to the public in the field of scientific and medical research in the field of medical marijuana; Providing information to the public in the field of scientific and medical research in the field of neurological diseases and disorders

Filing History

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Aug 17, 2026 GNS3
LETTER OF SUSPENSION E-MAILED
Aug 17, 2026 GNSL
SUSPENSION LETTER WRITTEN
Aug 17, 2026 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 15, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 15, 2026 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Aug 10, 2026 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
May 19, 2026 GNS2
INQUIRY TO SUSPENSION E-MAILED
May 19, 2026 GNSI
SUSPENSION INQUIRY WRITTEN
May 19, 2026 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
May 1, 2026 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Aug 25, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Aug 25, 2025 GNSL
SUSPENSION LETTER WRITTEN
Aug 25, 2025 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 25, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 25, 2025 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Aug 22, 2025 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jun 11, 2025 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jun 11, 2025 GNSI
SUSPENSION INQUIRY WRITTEN
Jun 11, 2025 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
May 23, 2025 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Nov 22, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Nov 22, 2024 GNSL
SUSPENSION LETTER WRITTEN
Nov 22, 2024 CNSL
ASSIGNED TO EXAMINER
Nov 18, 2024 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 15, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 15, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Nov 15, 2024 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Aug 26, 2024 GNFN
FINAL REFUSAL E-MAILED
Aug 26, 2024 GNFR
FINAL REFUSAL WRITTEN
Aug 26, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 29, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 29, 2024 CRFA
ASSIGNED TO LIE
Feb 29, 2024 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 10, 2023 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jul 7, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jul 7, 2023 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 11, 2023 GNRN
NON-FINAL ACTION E-MAILED
Apr 11, 2023 GNRT
NON-FINAL ACTION WRITTEN
Apr 11, 2023 CNRT
ASSIGNED TO EXAMINER
Apr 10, 2023 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Nov 2, 2021 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 1, 2021 NWOS
NEW APPLICATION ENTERED
Oct 11, 2021 NWAP